MedPath
NMPA Approval

水杨酸甲酯

国药准字H20043365

May 14, 2024

Drug Information

水杨酸甲酯

原料药

化学药品

May 14, 2024

Company Information

Applicant Company

Manufacturing Company

广东省佛山市南海区里水镇沙涌村下亨田工业区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

水杨酸甲酯 - NMPA 批准文号 | MedPath